Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 94INDUSTRY 46NIH 17NETWORK 10OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 7Rectal Neoplasms 3Neoplasm Metastasis 2Colonic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Liver Metastases of Colorectal Cancer 1Head and Neck Neoplasms 1

Interventions

Sentinel Lymph Node Biopsy 2Chemoradiotherapy 2pembrolizumab 1apatinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Positron Emission Tomography Computed Tomography 1Observation 1Moxibustion 1Low-Level Light Therapy 1Liquid Biopsy 1Erlotinib Hydrochloride 1DMAC2L protein, human 1Control Groups 1Cisplatin 1Cetuximab 1Celecoxib 1Acupuncture Therapy 126S proteasome non-ATPase regulatory subunit 13 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Squamous Cell Carcinoma of Head and Neck × Cetuximab × Clear all
NCT01301248 2011-05-17

Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) of the Head and Neck

Theagenio Cancer Hospital

Phase 2 Unknown
80 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡